###begin article-title 0
###xml 45 50 <span type="species:ncbi:9606">human</span>
Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 943 972 943 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bone morphogenetic protein 2 </italic>
###xml 973 978 973 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2</italic>
###xml 1152 1159 1152 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB-1 </italic>
###xml 1308 1315 1308 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 1458 1465 1458 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL2A1 </italic>
###xml 1735 1744 1735 1744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1748 1755 1748 1755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 499 507 <span type="species:ncbi:9606">patients</span>
###xml 580 587 <span type="species:ncbi:9606">patient</span>
###xml 1599 1604 <span type="species:ncbi:10090">mouse</span>
Acute full thickness joint surface defects can undergo repair, which involves tissue patterning and endochondral bone formation. Molecular signals regulating this process may contribute to the repair outcome, chronic evolution and, eventually, the onset of osteoarthritis. We tested the hypothesis that mechanical injury modulates morphogenetic pathways in adult human articular cartilage explants. Adjacent articular cartilage explants were obtained from preserved areas of the femoral condyles of patients undergoing arthroplasty for osteoarthritis, or from a normal joint of a patient undergoing lower limb amputation. Paired explants were individually maintained in explant culture. From each pair, one explant was mechanically injured and the other left uninjured as a control. Cultures were terminated at different time points for histochemistry, immunohistochemistry and gene expression analysis by reverse transcription real time PCR. Bone morphogenetic protein 2 (BMP-2) mRNA was upregulated in the injured explants. We detected phosphorylation of SMAD-1 and SMAD-5, consistent with activation of the bone morphogenetic protein (BMP) pathway. FRZB-1 mRNA was downregulated in the injured explants, suggesting de-repression of WNT signaling. Accordingly, expression of the canonical WNT target genes Axin-2 and c-JUN was upregulated in the injured explants. Activation of the canonical WNT signaling pathway by LiCl treatment induced upregulation of COL2A1 and Aggrecan mRNA, suggesting an anabolic effect. Phosphorylation of SMAD-1/-5 and downregulation of FRZB were confirmed in vivo in a mouse model of joint surface injury. Taken together, these data show modulation of the BMP and WNT pathways following mechanical injury in vitro and in vivo, which may play a role in the reparative response of the joint surface. These pathways may, therefore, represent potential targets in protocols of biological joint surface defect repair.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
Chronic symptomatic full thickness defects of the joint surface are commonly regarded to have a poor repair capacity. Therefore, surgical treatment is provided for symptomatic relief and in an attempt to avoid possible evolution towards osteoarthritis (OA) [1]. The natural history of acute full thickness joint surface defects (JSDs), however, is not yet well known. Scattered clinical and animal studies have suggested that acute full thickness JSDs exhibit potential for repair, which is dependent on age, the size of the lesion, and biomechanical factors.
###end p 4
###begin p 5
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 499 500 499 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 631 632 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 914 915 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 458 466 <span type="species:ncbi:9606">patients</span>
###xml 620 627 <span type="species:ncbi:9986">rabbits</span>
###xml 638 642 <span type="species:ncbi:9615">dogs</span>
###xml 651 658 <span type="species:ncbi:9986">rabbits</span>
In two independent, long term, prospective studies, acute traumatic chondral lesions in young athletes had a good to excellent clinical outcome in 78% of the cases in the absence of specific surgical treatments [2,3]. In addition, Koshino and colleagues [4] reported significant regeneration of chronic JSDs associated with genu varu at 2 years after correction of knee malalignment by valgus osteotomy. Age dependent spontaneous repair has been reported in patients with osteochondritis dissecans [5]. Likewise, age dependent spontaneous repair of relatively small experimental full thickness JSDs has been reported in rabbits [6,7] and dogs [8]. In rabbits, this repair process entails invasion of the fibrin clot, filling the defect by mesenchymal progenitors, chondrogenesis, and endochondral bone formation. Bone formation is polarized towards the joint surface, and preserves a layer of articular cartilage [6]. Although the repair tissue is not always durable and advancement of the bone front at the expense of stable articular cartilage sometimes occurs, this repair process, under specific conditions, can restore joint surface homeostasis.
###end p 5
###begin p 6
The patterning and morphogenesis that joint surface repair entails implies a stepwise cellular and molecular program. Thus, failure of the signaling mechanisms governing this process may be a factor contributing to a poor repair outcome. Such signals may represent therapeutic targets to support spontaneous repair or complement existing biological joint resurfacing techniques.
###end p 6
###begin p 7
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 639 646 639 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The current surgical approaches for localized full thickness lesions of the joint surface are autologous chondrocyte implantation, microfracture, and mosaicplasty. However, clinical outcomes suffer from some degree of variability [9-11]. In addition, there is still no satisfactory biological regeneration protocol for non-localized lesions. An alternative or complementary approach for joint tissue repair would be the controlled delivery of molecular signals to mesenchymal progenitors reported within the joint environment [12-18] with support of the subsequent steps of repair, including proliferation, patterning, and differentiation in vivo.
###end p 7
###begin p 8
###xml 165 174 165 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 214 219 <span type="species:ncbi:9606">human</span>
In this study, we have tested the hypothesis that the adult human articular cartilage is a source of morphogenetic signals upon injury. To this end, we have used an in vitro model of mechanical injury to the adult human articular cartilage to screen signaling pathways potentially involved in the repair response. In particular, we have focused on the bone morphogenetic protein (BMP) and the canonical WNT pathways, which are known to play a crucial role in joint morphogenesis and homeostasis as well as in repair processes [19-21].
###end p 8
###begin p 9
###xml 340 342 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
BMPs are secreted molecules belonging to the transforming growth factor beta superfamily of morphogens. Upon binding their ligands, BMP receptors phosphorylate the carboxy-terminal domain of SMAD-1, SMAD-5 and SMAD-8. Phosphorylated SMADS translocate to the nucleus where they participate in the transcriptional regulation of target genes [20].
###end p 9
###begin p 10
###xml 690 692 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
WNTs constitute a large family of morphogens. WNT ligands transduce their signal through different intracellular pathways. In the beta catenin-dependent (canonical) pathway, in the absence of WNT ligands, glycogen synthase kinase 3 (GSK-3) constitutively phosphorylates beta catenin, which then is degraded through the proteasome pathway. When WNT ligands bind to their receptors (called FRZD), GSK-3 is inhibited and beta catenin is, therefore, stabilized and accumulates in the cytoplasm and translocates into the nucleus, where it binds to members of the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription factors, thereby activating transcription of target genes [22].
###end p 10
###begin title 11
Materials and methods
###end title 11
###begin title 12
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ex vivo </italic>
Ex vivo cartilage injury model and tissue culture
###end title 12
###begin p 13
###xml 1152 1154 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
###xml 355 362 <span type="species:ncbi:9606">patient</span>
Well-preserved (modified Mankin score 5 or less) cartilage samples were obtained from patients who underwent total knee replacement for unicompartmental OA (e.g., lateral condyle in genu varu). The average age was 67.5 +/- 8.9 years old and the study included 3 males and 5 females. In one case (male, 49 years old), we obtained cartilage explants from a patient who had undergone limb amputation due to a road traffic accident and was free from OA. In this case, therefore, the cartilage was considered normal. Paired adjacent explants of approximately 6 x 6 mm were maintained in culture in 4 ml of Dulbecco's modeified Eagle's medium/HAMF12 1:1 (Invitrogen, Paisley, UK) in the presence or in the absence of 10% FBS (Invitrogen) and antibiotics/antimycotics (Invitrogen) in individual 33 mm bacteriological Petri dishes (BD Falcontrade mark, BD Biosciences, Le Pont De Claix, France). We used bacteriological Petri dishes to avoid spreading of cells from the explants. After 6 days, the medium was replaced and one of each pair of adjacent samples was cut using a scalpel at 1 mm intervals. The other explant of each pair was left uninjured (Figure 1a). At different time points, the explants were used for RNA extraction and one aliquot was processed for histology and immunohistochemistry.
###end p 13
###begin p 14
For experiments investigating activation of the WNT/beta catenin canonical pathway by means of LiCl treatment, the explants were maintained for 6 days in complete culture medium containing 10 mM NaCl. At the end of this period, the explants were either switched to medium containing 10 mM LiCl or, for control explants, the medium was replaced with fresh medium containing 10 mM NaCl. The experiments were then terminated after one day. All procedures received approval from the local ethics committee.
###end p 14
###begin title 15
RNA extraction, reverse transcription PCR and quantitative real time RT-PCR
###end title 15
###begin p 16
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 576 580 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 824 829 <span type="species:ncbi:9606">human</span>
Cartilage samples were snap-frozen in liquid nitrogen, powdered with a mortar and pestle in liquid nitrogen, and subsequently homogenized in Trizol reagent (Life Technologies, Invitrogen, Paisley, UK) using a polytron homogenizer. Total RNA was extracted using Trizol reagent. Reverse transcription PCR (RT-PCR) was performed as described elsewhere [23]. Quantitative real time RT-PCR (Q-PCR) was performed using hot start DNA polymerase (Quiagen Ltd, Crawley, UK) in the presence of 0.1X SYBR Green (Molecular Probes, Invitrogen, Paisley, UK) utilizing the DNA Engine Opticon(R) 2 System (MJ Research, Alpha technologies Ltd, Northern Ireland). Reactions were performed in duplicate and repeated in the rare cases when the Ct of the duplicates differed for more than 1 cycle. A serial dilution of a cDNA from early passage human articular chondrocytes was used for a standard curve. Gene expression was calculated using a standard curve and normalized for the expression of the housekeeping gene beta actin. To simplify the representation of time course analyses, the gene expression data normalized for beta actin are shown as fold increase from uninjured paired control.
###end p 16
###begin p 17
###xml 40 51 40 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </italic>
###xml 154 160 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-3 </italic>
###xml 262 268 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP13 </italic>
###xml 372 378 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 478 483 475 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 577 590 574 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; catenin </italic>
###xml 683 688 677 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT1 </italic>
###xml 781 787 775 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT5A </italic>
###xml 880 886 874 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT5B </italic>
###xml 981 987 975 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT14 </italic>
###xml 1084 1090 1078 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT16 </italic>
###xml 1187 1194 1181 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZD-1 </italic>
###xml 1289 1296 1283 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZD-7 </italic>
###xml 1395 1401 1389 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEF-1 </italic>
###xml 1502 1508 1496 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF-1 </italic>
###xml 1606 1613 1600 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL2A1 </italic>
###xml 1710 1719 1704 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aggrecan </italic>
###xml 1817 1823 1811 1817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
Primers and expected amplicon size are: beta-actin (GeneBank:), forward 5'-CACGGCTGCTTCCAGCTC-3', reverse 5'-CACAGGACTCCATGCCCAG-3', 134 base pairs (bp); MMP-3 (GeneBank:), forward 5'-CAACCGTGAGGAAAATCGATGCAG-3', reverse 5'-CGGCAAGATACAGATTCACGCTCAA-3', 440 bp; MMP13 (GeneBank:), forward 5'-ACGGACCCATACAGTTTGAATACAGC-3', reverse 5'-CCATTTGTGGTGTGGGAAGTATCATC-3, 360 bp; BMP-2 (GeneBank:), forward 5'-CGTCAAGCCAAACACAAACAGCG-3', reverse 5'- CACCCACAACCCTCCACAACCAT-3', 341 bp; FRZB (GeneBank:), forward 5'GGGCTATGAAGATGAGGAACGT-3', reverse 5'-ACCGAGTCGATCCTTCCACTT-3', 79 bp; beta catenin (GeneBank:), forward 5'-CCAGCCGACACCAAGAAGCA-3', reverse 5'-GCGGGACAAAGGGCAAGATT-3', 151 bp; WNT1 (GeneBank:), forward 5'-CTGCCTCTCTTCTTCCCCTT-3', reverse 5'-TCACAGCTGTTCAATGGCTC-3', 251 bp; WNT5A (GeneBank:), forward 5'-CCACCTTCCTCTTCACACTG-3', reverse 5'-CGAACAAGTAATGCCCTCTC-3', 770 bp; WNT5B (GeneBank:), forward 5'- CCGCCTCTGCAACAAGACCT-3', reverse 5'- AACTTGCAGTGGCAGCGCTC-3', 111 bp; WNT14 (GeneBenk:), forward 5'- TGAGAAGAACTGCGAGAGCA -3', reverse 5'- CTGTGTGCAATGCCTGTACC -3', 285 bp; WNT16 (GeneBank:), forward 5'- AAAGAAATGTTTCCCTGCCC -3', reverse 5'- GACATTTTCCATGGGTTTGC -3', 106 bp; FRZD-1 (GeneBank:), forward 5'- TTCAGCAGCACATTCTGAGG-3', reverse 5'- CCTGCACACATTTTCCCTTT-3', 154 bp; FRZD-7 (GeneBank:), forward 5'- CTGGAGTTCTTTGAAATGTGCT-3', reverse 5'- AAGGTTAGCTCCCATGATTCTC-3', 133 bp; LEF-1 (GeneBank:), forward 5'- CAGAGAAAGGAGCAGGAGCCAA -3', reverse 5'- TGATGTCAGTGTTCCTTTGGCG -3', 481 bp; TCF-1 (GeneBank:), forward 5'- CTCATCACCGACACCACCAACC-3', reverse 5'- TCCCACGAAGCAGCGACAGT -3', 608 bp; COL2A1 (GeneBank:), forward 5'- CCCTGAGTGGAAGAGTGGAG -3', reverse 5'- GAGGCGTGAGGTCTTCTGTG -3', 511 bp; Aggrecan (GeneBank:), forward 5'- GTTGTCATCAGCACCAGCATC -3', reverse 5'- ACCACACAGTCCTCTCCAGC -3', 509 bp; c-JUN (GeneBank:), forward 5'-CCCCAAGATCCTGAAACAGA-3', reverse 5'- CCGTTGCTGGACTGGATTAT-3'.
###end p 17
###begin title 18
Histology, histochemistry and immunohistochemistry
###end title 18
###begin p 19
###xml 286 288 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1812 1816 1780 1782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 2319 2320 2285 2286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2321 2322 2287 2288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2352 2354 2318 2320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 942 948 <span type="species:ncbi:9913">bovine</span>
###xml 1063 1067 <span type="species:ncbi:9925">goat</span>
###xml 1073 1078 <span type="species:ncbi:10090">mouse</span>
###xml 1079 1084 <span type="species:ncbi:9606">human</span>
###xml 1122 1127 <span type="species:ncbi:10090">mouse</span>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
###xml 1252 1258 <span type="species:ncbi:9913">bovine</span>
###xml 1449 1455 <span type="species:ncbi:9986">rabbit</span>
###xml 1461 1465 <span type="species:ncbi:9925">goat</span>
###xml 1604 1608 <span type="species:ncbi:9925">goat</span>
###xml 1614 1619 <span type="species:ncbi:10090">mouse</span>
###xml 2524 2529 <span type="species:ncbi:9940">sheep</span>
###xml 2535 2541 <span type="species:ncbi:9986">rabbit</span>
###xml 3191 3197 <span type="species:ncbi:9986">rabbit</span>
Tissues were fixed overnight in 4% buffered paraformaldehyde at 4degreesC, dehydrated and embedded in paraffin. Sections (5 mum thick) were used for hematoxylin-eosin and safranin O staining according to standard protocols. The degree of OA was evaluated using a modified Mankin score [24] in which the sub-score related to the tide mark was not included. For immunohistochemistry, paraffin sections were deparaffinized and hydrated in xylene and an ethanol series, post-fixed with 4% paraformaldehyde, and washed twice in phosphate-buffered saline. For antigen retrieval in the detection of FRZB and beta catenin, the sections were first equilibrated in 0.02% HCl for 7 minutes, digested in 3 mg/ml pepsin (Sigma-Aldrich Company Ltd., Gillingham, UK) in 0.02% HCl for 45 minutes at 37degreesC, washed in water and allowed to air dry for 20 minutes. Sections were washed twice in 0.2% Tween-20 in tris buffered saline (TBST), blocked in 0.5% bovine serum albumin in TBST for 1 hour at room temperature, blotted, and incubated overnight with the primary antibody (goat anti-mouse/human FRZB (R&D Systems, Abingdon, UK), or mouse anti-human beta catenin (BD Transduction Laboratories, BD, Cowley, Oxford, UK) at a final concentration of 1 mug/ml in 0.5% bovine serum albumin in TBST. Sections were then washed twice in TBST, and incubated for 1 hour with the secondary antibody. For FRZB immunostaining, the secondary antibody was a biotin-conjugated rabbit anti-goat antibody (DAKO UK Ltd., Ely Cambridgeshire, UK) diluted 1:300. For beta catenin immunostaining, we used either a cytrade mark2 conjugated goat anti-mouse antibody (Jackson ImmunoResearch Laboratories, Inc. West Grove, PA, USA) diluted 1:200 for indirect immunofluorescence, or the StreptABComplex/AP kit (DAKO) for signal amplification and Vector(R) Red substrate kit (Vector Laboratories UK, Peterborough, UK) as a chromogenic substrate of alkaline phosphatase, in the presence of 0.2 mM levamisole to inhibit endogenous alkaline phosphatase. For the detection of phosphorylated SMAD-1 and SMAD-5, we used the same protocol with the following modifications. For antigen retrieval, instead of pepsin digestion, we boiled the sections for 10 minutes in sodium citrate buffer, pH 6; we quenched endogenous peroxidase by incubating for 10 minutes with 9% H2O2; we used the PS-1 antiserum [25] (a kind gift of P ten Dijke and C-H Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden) as primary antibody; as secondary antibody we used biotin-conjugated sheep anti-rabbit antibody (Serotec UK, Oxford, UK) diluted 1:200; we used the StreptABComplex/AP kit (DAKO) as an amplification system, and Liquid DAB Substrate Chromogen System (DAKO) as peroxidase substrate. Sections were mounted in mowiol (Calbiochem, Merck Biosciences Ltd, Nottingham, UK) containing 49,6-diamidino-2-phenylindole (DAPI; ICN, Stretton Scientific Ltd., Stretton, UK) for nuclear counterstaining. In positive cells the DAB precipitate quenched the DAPI fluorescence. Image processing was performed using Adobe Photoshop version 6 (Adobe). Negative controls were sections in which isotype and species-matched non-specific immunoglobulins or normal rabbit serum (for phospho-SMAD-1/-5) were used instead of the primary antibody.
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
###xml 82 84 82 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
Normally distributed data sets from paired samples were compared using the paired t test. When the values did not have a normal distribution, they were either transformed into their logarithms before analysis or, if this still did not result in a normal distribution, they were analyzed using the Wilcoxon matched pair test.
###end p 21
###begin title 22
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Joint surface injury in mice
###end title 22
###begin p 23
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 497 501 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
Seven week old C57BL/6 male mice were utilized for these experiments. The mice were anesthetized and subjected to medial para-patellar arthrotomy. The patellar groove was exposed by lateral patellar dislocation. A longitudinal full thickness injury was made in the patellar groove using a custom made device in which the length of a 26G needle was limited by a glass bead (injured knee). The patellar dislocation was then reduced and the joint capsule and the skin sutured in separate layers. The mice were then allowed to walk freely in standard cages and maintained on free diet. Control mice were subjected to the arthrotomy and to the patellar dislocation, but no cartilage injury was made (sham operated controls). The animals were killed at different time-points and the knees dissected for histological and histochemical analysis. The same procedure has been performed in 9 month old mice of the same strain and sex and produced analogous results.
###end p 23
###begin title 24
Results
###end title 24
###begin title 25
###xml 3 12 3 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
An in vitro model of mechanical injury to adult human articular cartilage
###end title 25
###begin p 26
###xml 119 128 119 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 362 371 362 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 541 550 541 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 554 562 554 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 620 626 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-3 </italic>
###xml 630 637 630 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-13 </italic>
###xml 723 725 723 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 744 746 744 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 757 762 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-3</italic>
###xml 764 766 764 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 777 783 777 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-13</italic>
###xml 805 809 805 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c,d</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
To screen for signaling molecules regulated by mechanical damage in adult human articular cartilage we have adapted an in vitro model of mechanical cartilage injury (Figure 1a). Under our experimental conditions, uninjured explants preserved metachromatic staining with safranin O (Figure 1b) and toluidine blue (not shown) for at least 6 days. To validate this in vitro assay, we tested if we could detect in this injury model upregulation of metalloproteinase (MMP)-3 and MMP-13, as has been reported following mechanical cartilage injury in vitro and in vivo [26-28]. Under our experimental conditions, expression of MMP-3 and MMP-13 mRNA was significantly upregulated in the injured explants of each pair at the day 1 (p < 0.05) and day 6 (p < 0.01 for MMP-3; p < 0.05 for MMP-13) time points (Figure 1c,d).
###end p 26
###begin title 27
Morphogenetic pathways modulated by mechanical injury
###end title 27
###begin p 28
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 422 424 422 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
We then performed a differential gene expression analysis by Q-PCR, comparing the injured versus the paired uninjured explants by focusing on molecular pathways known to play a role in embryonic skeletogenesis and in the repair of other tissues. We detected statistically highly significant upregulation of BMP-2 mRNA (Figure 2a) and down-regulation of the secreted WNT inhibitor FRZB mRNA (Figure 2b) 1 day after injury (p < 0.01).
###end p 28
###begin title 29
Mechanical injury is associated with modulation of the BMP pathway
###end title 29
###begin p 30
###xml 36 42 36 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 182 184 182 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 397 399 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 423 429 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 549 555 549 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
To determine the temporal window of BMP-2 mRNA regulation, we performed a time course gene expression analysis at 5 hours, 1 day, and 6 days after injury. Statistically significant (p < 0.05) upregulation of BMP-2 was detected already 5 hours after wounding and tended to subside within 6 days (Figure 3a). Similar results were obtained in the absence of serum, where a statistically significant (p < 0.05) upregulation of BMP-2 mRNA was present 5 hour after injury (Figure 3b), indicating that, under our experimental conditions, the regulation of BMP-2 expression in response to mechanical injury is not serum dependent.
###end p 30
###begin p 31
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3f&#8211;h</xref>
###xml 694 700 694 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c&#8211;e,h</xref>
###xml 938 943 938 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2</italic>
###xml 945 950 945 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-3</italic>
###xml 956 963 956 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-13 </italic>
###xml 1113 1118 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 1415 1416 1415 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1360 1365 <span type="species:ncbi:10090">mouse</span>
To test whether the adult cartilage tissue is itself a target of BMP signaling, we performed immunohistochemistry using an antibody that recognizes the phosphorylated form of the MAD homology domain 2 of SMAD-1 and SMAD-5 [25]. In the explant pair obtained from normal articular cartilage, we detected phospho-SMAD-1/-5-positive chondrocytes in all cartilage layers in the uninjured as well as the injured explants (83% in the uninjured explant versus 100% in the injured) (Figure 3f-h). However, in adjacent uncultured freshly dissected articular cartilage, the proportion of phospho-SMAD-1/-5-positive cells was 41%, with nearly all positive cells localized in the intermediate layer (Figure 3c-e,h). These results suggest that the dissection of the cartilage explants from the joints may be associated with a molecular response to wounding, which the resting period in culture reverted only partially. Consistent with this hypothesis, BMP-2, MMP-3, and MMP-13 mRNA levels were lowest in the freshly dissected cartilage, intermediate in the uninjured cultured explant, and highest in the injured explant, while FRZB mRNA levels had an opposite trend. Similar results for the proportions of phospho-SMAD-1/-5-positive cells were found in injured and uninjured cartilage explants from OA cartilage. Finally, SMAD-1/5 phosphorylation was confirmed in vivo in a mouse model of mechanical joint surface injury (Figure 4). Full characterization of this model represents an ongoing effort in our laboratory.
###end p 31
###begin title 32
Activation of the WNT pathway following cartilage mechanical injury
###end title 32
###begin p 33
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 455 457 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 542 544 542 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 736 740 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c&#8211;f</xref>
###xml 806 808 806 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 978 980 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5g</xref>
###xml 1037 1045 1037 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1094 1095 1094 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1144 1149 1144 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 1339 1341 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1342 1344 1342 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1435 1440 1435 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT-1</italic>
###xml 1442 1448 1442 1448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT-5a</italic>
###xml 1450 1456 1450 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT-5b</italic>
###xml 1458 1467 1458 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT-9a/14</italic>
###xml 1473 1478 1473 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT16</italic>
###xml 1492 1499 1492 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZD-1 </italic>
###xml 1503 1509 1503 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZD-7</italic>
###xml 1603 1607 1600 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF </italic>
###xml 1611 1617 1608 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEF-1 </italic>
###xml 1712 1716 1706 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5h&#8211;m</xref>
###xml 1050 1055 <span type="species:ncbi:10090">mouse</span>
###xml 1310 1315 <span type="species:ncbi:10090">mouse</span>
###xml 1369 1374 <span type="species:ncbi:9606">human</span>
In a time course analysis, FRZB mRNA was already down-regulated in some but not all explant pairs 5 hours after injury (Figure 5a). Similar results were obtained with serum free culture conditions (Figure 5b), thereby demonstrating that, under our experimental conditions, FRZB mRNA regulation in response to mechanical injury was not dependent on the presence of FBS in the culture medium. Statistical analysis confirmed a highly significant difference (p < 0.01) at the day 1 time point in the presence of FBS and a significant difference (p < 0.05) at the 5 hour and day 1 time points in the absence of serum. At the protein level, FRZB was present in both injured and uninjured explants as evaluated by immunohistochemistry (Figure 5c-f). The proportion of FRZB positive cells was significantly lower (p < 0.05) in the injured explant in three independent explant pairs, confirming at the protein level the down-regulation of FRZB expression in the injured explants (Figure 5g). Downregulation of FRZB was confirmed at protein level in vivo in a mouse model of joint surface injury (Figure 4). The down-regulation of the secreted inhibitor FRZB suggests de-repression of WNT signaling. Thus, we next investigated whether the expression of components of the WNT pathway that are present in cartilage during mouse embryonic development [29,30] is maintained in adult human articular cartilage. We detected mRNA encoding WNT ligands (WNT-1, WNT-5a, WNT-5b, WNT-9a/14, and WNT16), receptors (FRZD-1 and FRZD-7), intracellular mediators such as beta-catenin, and downstream transcription factors such as TCF and LEF-1 (data not shown). The presence of beta-catenin was also confirmed at the protein level (Figure 5h-m).
###end p 33
###begin p 34
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 184 190 184 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 297 304 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 363 365 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a</xref>
###xml 420 422 417 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 431 437 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
###xml 438 440 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 441 443 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 469 471 466 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 549 556 546 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 564 566 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6b</xref>
###xml 585 592 582 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 596 602 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
###xml 871 873 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 894 901 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 905 911 899 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
###xml 947 949 941 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1066 1070 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c,d</xref>
###xml 1230 1237 1224 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL2A1 </italic>
###xml 1241 1250 1235 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aggrecan </italic>
###xml 1353 1355 1347 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1375 1382 1369 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL2A1 </italic>
###xml 1386 1395 1380 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aggrecan </italic>
###xml 1439 1443 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6e,f</xref>
###xml 1149 1154 <span type="species:ncbi:9606">human</span>
We then investigated whether mechanical injury resulted in a net activation of the canonical WNT pathway by performing gene expression analysis of the WNT target genes Axin-2 [31] and c-JUN [32,33]. Consistent with our hypothesis and with the activation of the WNT/beta-catenin signaling pathway, Axin-2 mRNA was upregulated 1 day after mechanical injury (Figure 6a), with a statistically highly significant difference (p < 0.01). c-JUN [32,33] was also significantly (p < 0.05) upregulated in the injured explants, although to a lesser extent then Axin-2 (Figure 6b). To confirm that Axin-2 and c-JUN mRNA are WNT targets in adult articular cartilage and under our experimental conditions, we monitored the expression of these genes after treatment with 10 mM LiCl, an inhibitor of GSK-3 and, therefore, an activator of the beta catenin-dependent WNT signaling pathway [34]. The expression of Axin-2 and c-JUN was consistently and significantly (p < 0.05) upregulated in the LiCl-treated explants compared with the paired control explants treated with NaCl (Figure 6c,d). To test the effects of the activation of the canonical WNT pathway in adult human articular cartilage, we determined the expression of the cartilage markers COL2A1 and Aggrecan in LiCl treated and control cultures. Under our experimental conditions, LiCl treatment significantly (p < 0.05) upregulated COL2A1 and Aggrecan mRNA, suggesting an anabolic effect (Figure 6e,f).
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 356 357 356 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 360 361 360 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 521 522 521 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 730 738 730 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 900 906 900 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 315 321 <span type="species:ncbi:9606">humans</span>
###xml 831 836 <span type="species:ncbi:9606">human</span>
The articular cartilage of adult individuals is commonly regarded as a passive target of different pathogenic elements, such as mechanical wear and inflammation, leading to cartilage matrix breakdown and loss of chondrocytes. However, acute, small, full thickness JSDs appear to have repair capacity in animals and humans, especially in young individuals [2,3,5-8]. Repair of full thickness JSDs involves coordination of patterning and tissue maturation that recapitulates some aspects of embryonic skeletal development [6], thereby requiring morphogenetic signaling. Here we have tested the hypothesis that the injured articular cartilage may be a source of morphogenetic signals activated by damage. To this end we have used an ex vivo model to investigate the modulation of gene expression induced by mechanical injury to adult human articular cartilage explants. We have detected upregulation of BMP-2 mRNA after injury. Several factors can determine activation of BMP signaling independently of the expression of one ligand, including secretion and solubility of the ligand(s), its/their binding to matrix molecules, the presence of secreted or intracellular inhibitors and receptor regulation [35]. Our data showing phosphorylation of SMAD-1/-5 suggest activation of BMP signaling.
###end p 36
###begin p 37
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 557 563 557 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 603 612 603 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 681 688 681 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1180 1182 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1202 1204 1202 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1355 1357 1355 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
###xml 627 632 <span type="species:ncbi:9606">human</span>
BMPs elicit a well-documented anabolic response on cartilage explants [20], and genetic evidence has been provided that the BMP pathway is needed for joint homeostasis in adulthood [36]. Indeed, targeted deletion of the gene encoding BMP receptor 1A in the articular cartilage in mice results in joint surface degeneration resembling OA [36]. In addition, BMPs have been shown to regulate recruitment of chondroprogenitors [37], synthesis of cartilage matrix, and endochondral bone formation [20] during embryonic skeletogenesis. Finally, the expression of BMP-2 mRNA is associated with the capacity of in vitro expanded adult human articular chondrocytes to form stable cartilage in vivo, resistant to vascular invasion and endochondral bone formation [23]. Therefore, the recruitment of progenitor cells, the regulation of endochondral bone formation and cartilage extracellular matrix synthesis, as well as the preservation of the phenotypic stability of articular chondrocytes are all potential roles of BMP signaling in JSD repair. However, it must be underscored that BMP signaling also plays a part in the pathogenesis of joint diseases such as osteophyte formation in OA [38] and enthesopathy [39]. Finally, upregulation of BMP-2 has already been reported following exposure of cartilage explants to interleukin 1 and tumor necrosis factor alpha [40]. It is possible, therefore, that upregulation of BMP-2 may represent a response of the articular cartilage to different types of injuries.
###end p 37
###begin p 38
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 336 343 333 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 347 352 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN</italic>
###xml 417 419 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 523 528 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 833 838 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 888 890 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 880 886 <span type="species:ncbi:9606">humans</span>
In addition to the upregulation of BMP-2 mRNA, we have documented a consistent injury-associated down-regulation of the secreted WNT inhibitor FRZB, suggesting de-repression of the WNT signaling pathway. Consistently, we have detected, in the injured explants, upregulation of mRNA encoding the WNT/beta catenin transcriptional targets Axin-2 and c-JUN. The WNT signaling pathway can be regulated at multiple levels [22] and, therefore, our experimental setup does not allow determining whether the decreased expression of FRZB mRNA is responsible for the detected upregulation of the WNT/beta catenin target genes. Nevertheless, the functional importance of the regulation of FRZB expression in the context of joint homeostasis is underscored by the observation that a single nucleotide polymorphism causing loss of function of the FRZB gene product is associated with hip OA in humans [41].
###end p 38
###begin p 39
###xml 248 250 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 251 253 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 427 429 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 430 432 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 788 790 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 791 793 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 920 927 914 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL2A1 </italic>
###xml 931 940 925 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aggrecan </italic>
###xml 1083 1085 1077 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1086 1088 1080 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 1089 1091 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1398 1400 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1953 1955 1944 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 841 846 <span type="species:ncbi:9606">human</span>
The function of WNT signaling in the context of joint surface defect repair is still poorly understood. Studies on embryonic tissues indicate that the activation of the canonical beta catenin pathway plays an important role in joint specification [30,42] and in the regulation of chondrocyte differentiation inhibiting chondrogenesis in immature mesenchymal cells and enhancing terminal differentiation in mature chondrocytes [29,32]. However, while the data in embryonic tissues suggest a general inhibitory effect of canonical WNT signaling on chondrogenesis, in experimental models utilizing adult cells, the activation of the beta catenin-dependent canonical WNT pathway, under specific experimental conditions, rather appears to promote chondrogenesis and cartilage differentiation [43-45]. This is in line with our findings that adult human articular cartilage explants cultured in the presence of LiCl upregulate COL2A1 and aggrecan mRNA. Since in other organ systems WNTs are involved in supporting repair processes by maintaining a stem cell pool and specifying cell fates [19,46,47], it is tempting to speculate that the canonical WNT pathway would play a similar function in the repair of osteochondral defects. Finally, there is also evidence that WNTs, at least through the non-canonical pathway, may be implicated in joint inflammation and may be detrimental for cartilage integrity [48]. The most likely interpretation of these apparently contrasting data is that a tight regulation of the WNT and the BMP pathways is necessary for proper joint homeostasis and repair and that, in postnatal life, the same mechanisms that are set into action to support repair may also play a pathogenic role when de-regulated or when restoration of homeostasis fails. In this regard, it is interesting that gain or loss of function of beta catenin in the developing skeleton both result in severe chondrodysplasia, although through different mechanisms [49].
###end p 39
###begin p 40
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 189 196 <span type="species:ncbi:9606">patient</span>
###xml 200 207 <span type="species:ncbi:9606">patient</span>
We have encountered a high variability in the molecular responses to injury in different pairs of cartilage explants. This variability can be explained by the heterogeneity of tissues from patient to patient, and by our inability to obtain adequately 'homogeneous' preparation of the explants. Analogous variability has been reported in the molecular response of cartilage explants to inflammatory cytokines [50]. Indeed, the variability in the molecular response to injury could be a factor contributing to the variability in the clinical outcome of untreated acute articular cartilage injuries.
###end p 40
###begin p 41
###xml 168 174 168 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2</italic>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lrp5</italic>
###xml 452 456 452 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 908 910 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
In some experiments, the differences in gene expression were of small magnitude. However, we have observed a reproducible upregulation of WNT reporter genes, including Axin-2, following injury or LiCl treatment, which indicate that the modulation of the wnt signaling was sufficient to induce a transcriptional response. Axin-2 upregulation of approximately the same magnitude was reported to be associated with increased bone mass in osteoporotic lrp5-/- mice following oral administration of LiCl [51]. Remarkably, the plasma levels of LiCl achieved in that study were only 0.4 to 0.5 mM, which are insufficient to trigger detectable wnt responses in the classic assays such as beta catenin nuclear localization or activation of the TOP-FLASH reporter. It is reasonable that this magnitude of wnt activation in adult animals is probably more physiological than that achieved in overexpression experiments [51]. Indeed, in postnatal life, morphogenetic events take place at a much lower rate than in embryonic development and, therefore, slight changes in the balance of the morphogenetic pathways can result in significant biological effects.
###end p 41
###begin p 42
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 390 398 390 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 429 438 429 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 827 833 827 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3h</xref>
###xml 1287 1295 1287 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1344 1345 1344 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1376 1383 1376 1383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1300 1305 <span type="species:ncbi:10090">mouse</span>
The in vitro culture conditions may influence the molecular response to injury, potentially introducing artifacts. However, the reproducibility of FRZB and BMP-2 mRNA regulation in response to damage regardless of the presence of serum in the culture medium suggests that this response is largely not dependent on culture conditions. In addition, it is possible that the response to injury in vivo will be more vibrant than that in vitro because the resting period does not appear to be sufficient to completely reverse the response due to the initial dissection of the explants. In this respect, Vincent and colleagues [52] reported rapid phosphorylation of ERK following dissection of porcine articular cartilage explants, which was completely reverted after 48 hours of "resting" in culture. In our study, the modulation of BMP-2 and FRZB mRNA appear to last longer than 48 hours. This is also supported by the analysis of the sample in Figure 3h, in which the expression levels of all molecules tested and the number of phospho-SMAD-1/-5-positive cells in the rested explant were intermediate between the freshly dissected explant and the explant re-injured after the resting period. Most importantly, we have shown phosphorylation of SMAD-1/-5 and downregulation of FRZB expression in vivo in a mouse model of joint surface injury (Figure 4) not only confirming our data in vivo, but also suggesting that such mechanisms are evolutionarily conserved. Functional studies are being performed to evaluate the role of these molecular mechanisms in the context of cartilage damage and repair. Full characterization of this model is an ongoing effort in our laboratory.
###end p 42
###begin p 43
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 257 266 257 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Injuries to the articular cartilage result in activation of the bone marrow and subchondral bone remodeling [53], suggesting the presence of molecular signals that are released and target the neighboring tissues. We have demonstrated that mechanical injury in vitro can elicit the activation of two of the most important signaling pathways involved in embryonic skeletogenesis and joint morphogenesis, suggesting that the articular cartilage is capable of triggering a signaling machinery that may play a role in joint surface repair.
###end p 43
###begin p 44
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1328 1330 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1352 1354 1352 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1369 1371 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1402 1404 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1405 1407 1405 1407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1408 1410 1408 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1590 1598 1590 1598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo </italic>
###xml 1737 1739 1737 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
Although several risk factors for OA have been identified, including the nature and entity of the injury, age, genetic predisposition, and joint congruity, it is still not clear why some individuals can efficiently repair JSDs while some others will develop chronic symptomatic lesions requiring surgical intervention and possibly evolving into OA [1]. Failure of repair signaling may contribute to evolution towards OA. Our data suggest that morphogenetic pathways are transiently activated early following acute injury, as has been reported in other organ systems [19]. Insufficient or untimely activation of this machinery may result in repair failure. It is important, therefore, to study these events in a temporally dynamic fashion, and it is possible that the early post-traumatic signals may be critical for the final repair outcome. Understanding the molecular mechanisms of repair may help us define a more focused indication for biological JSD repair. On the other hand, the modulation of these signaling pathways (e.g., by controlled release of bioactive molecules from scaffolding biomaterials) may complement the available tissue engineering approaches to enhance specific aspects of repair. Finally, the persistence in adulthood of locally residing stem cells within several joint tissues, including bone marrow [54], synovial membrane [16], periosteum [13], and articular cartilage [12,14,15,18], opens the possibility to recruit and guide these cells locally using appropriate molecular signals to enhance repair. This would circumvent a number of problems associated with ex vivo cell manipulation, including phenotypic instability, high costs, non-optimal consistency, and complex regulation of the cellular products [55].
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 136 145 136 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
Our data show modulation of the WNT and BMP signaling pathways in adult human and mouse articular cartilage following mechanical injury in vitro and in vivo. These molecular events may contribute to trigger or support a repair response and failure to promptly activate these reparative signals may contribute to poor repair and poor clinical outcome. Hence, activation of the WNT and BMP pathways in response to injury may represent a prognostic marker and at the same time a therapeutic target to enhance the early response of the joint surface to acute injury.
###end p 46
###begin title 47
Abbreviations
###end title 47
###begin p 48
###xml 120 126 <span type="species:ncbi:9913">bovine</span>
BMP = bone morphogenetic protein; glycogen synthase kinase 3 = GSK-3; DAPI = 49,6-diamidino-2-phenylindole; FBS = fetal bovine serum; JSD = joint surface defect; MMP = metalloproteinase; OA = osteoarthritis; Q-PCR = quantitative real time PCR; RT-PCR = reverse transcription PCR; TBST = tris buffered saline; TCF/LEF = T-cell factor/lymphoid enhancer factor.
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
The authors declare that they have no competing interests.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
FD designed the study, performed the experiments and drafted the manuscript. CD was involved in the study design, in data interpretation, and drafting the manuscript. NE contributed to immunohistochemical stainings for FRZB. FB contributed to the optimization of the phospho-SMAD-1 staining. TM critically revised the manuscript for important intellectual content. JO critically revised the manuscript for important intellectual content. CP was involved in the study design, interpretation of the results and has critically reviewed the manuscript.
###end p 52
###begin title 53
Acknowledgements
###end title 53
###begin p 54
We wish to thank the Arthritis Research Campaign (ARC) for funding this work (grant no. D0603) and Dr Dell'Accio's Fellowship; the orthopedic surgeons at Guy's Hospital for providing cartilage samples; and Frank P Luyten for critically reviewing the manuscript.
###end p 54
###begin article-title 55
The impact of osteoarthritis: implications for research
###end article-title 55
###begin article-title 56
The long-term prognosis for severe damage to weight-bearing cartilage in the knee: a 14-year clinical and radiographic follow-up in 28 young athletes
###end article-title 56
###begin article-title 57
Outcome of untreated traumatic articular cartilage defects of the knee: a natural history study
###end article-title 57
###begin article-title 58
Regeneration of degenerated articular cartilage after high tibial valgus osteotomy for medial compartmental osteoarthritis of the knee
###end article-title 58
###begin article-title 59
Osteochondritis dissecans of the femoral condyles: a long-term follow-up study
###end article-title 59
###begin article-title 60
Cell origin and differentiation in the repair of full-thickness defects of articular cartilage
###end article-title 60
###begin article-title 61
###xml 70 76 <span type="species:ncbi:9986">rabbit</span>
Maturation-dependent repair of untreated osteochondral defects in the rabbit knee joint
###end article-title 61
###begin article-title 62
Chondral defects in animal models: effects of selected repair procedures in canines
###end article-title 62
###begin article-title 63
A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee
###end article-title 63
###begin article-title 64
Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial
###end article-title 64
###begin article-title 65
Autologous chondrocyte implantation for cartilage repair: monitoring its success by magnetic resonance imaging and histology
###end article-title 65
###begin article-title 66
###xml 59 64 <span type="species:ncbi:9606">human</span>
Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes
###end article-title 66
###begin article-title 67
###xml 34 39 <span type="species:ncbi:9606">human</span>
Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis
###end article-title 67
###begin article-title 68
###xml 76 81 <span type="species:ncbi:9606">human</span>
Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage
###end article-title 68
###begin article-title 69
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 70 75 <span type="species:ncbi:9606">human</span>
Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo
###end article-title 69
###begin article-title 70
###xml 46 51 <span type="species:ncbi:9606">human</span>
Multipotent mesenchymal stem cells from adult human synovial membrane
###end article-title 70
###begin article-title 71
###xml 32 37 <span type="species:ncbi:9606">human</span>
Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane
###end article-title 71
###begin article-title 72
The surface of articular cartilage contains a progenitor cell population
###end article-title 72
###begin article-title 73
Tissue repair and stem cell renewal in carcinogenesis
###end article-title 73
###begin article-title 74
Bone morphogenetic proteins and the synovial joints
###end article-title 74
###begin article-title 75
The control of chondrogenesis
###end article-title 75
###begin article-title 76
Convergence of Wnt, beta-catenin, and cadherin pathways
###end article-title 76
###begin article-title 77
###xml 57 62 <span type="species:ncbi:9606">human</span>
Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo
###end article-title 77
###begin article-title 78
###xml 84 89 <span type="species:ncbi:9606">human</span>
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data
###end article-title 78
###begin article-title 79
The L45 loop in type I receptors for TGF-beta family members is a critical determinant in specifying Smad isoform activation
###end article-title 79
###begin article-title 80
###xml 80 83 <span type="species:ncbi:9823">pig</span>
Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report
###end article-title 80
###begin article-title 81
Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression
###end article-title 81
###begin article-title 82
###xml 78 84 <span type="species:ncbi:10090">murine</span>
Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis
###end article-title 82
###begin article-title 83
###xml 57 64 <span type="species:ncbi:9031">chicken</span>
Dual roles of Wnt signaling during chondrogenesis in the chicken limb
###end article-title 83
###begin article-title 84
Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation
###end article-title 84
###begin article-title 85
###xml 110 115 <span type="species:ncbi:9606">human</span>
Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors
###end article-title 85
###begin article-title 86
Regulation of the chondrocyte phenotype by beta-catenin
###end article-title 86
###begin article-title 87
###xml 81 86 <span type="species:ncbi:9606">human</span>
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
###end article-title 87
###begin article-title 88
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor
###end article-title 88
###begin article-title 89
Bone morphogenetic proteins, their antagonists, and the skeleton
###end article-title 89
###begin article-title 90
BMP receptor signaling is required for postnatal maintenance of articular cartilage
###end article-title 90
###begin article-title 91
Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation
###end article-title 91
###begin article-title 92
Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis
###end article-title 92
###begin article-title 93
Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis
###end article-title 93
###begin article-title 94
Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes
###end article-title 94
###begin article-title 95
Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females
###end article-title 95
###begin article-title 96
Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton
###end article-title 96
###begin article-title 97
Demineralized bone alters expression of Wnt network components during chondroinduction of post-natal fibroblasts
###end article-title 97
###begin article-title 98
###xml 98 103 <span type="species:ncbi:9606">human</span>
Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells
###end article-title 98
###begin article-title 99
The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner
###end article-title 99
###begin article-title 100
Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes
###end article-title 100
###begin article-title 101
Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
###end article-title 101
###begin article-title 102
Expression and function of wingless and frizzled homologs in rheumatoid arthritis
###end article-title 102
###begin article-title 103
Interactions between Sox9 and beta-catenin control chondrocyte differentiation
###end article-title 103
###begin article-title 104
###xml 79 84 <span type="species:ncbi:9606">human</span>
Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage
###end article-title 104
###begin article-title 105
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice
###end article-title 105
###begin article-title 106
Basic FGF mediates an immediate response of articular cartilage to mechanical injury
###end article-title 106
###begin article-title 107
###xml 92 97 <span type="species:ncbi:9925">goats</span>
Subchondral bone reaction associated with chondral defect and attempted cartilage repair in goats
###end article-title 107
###begin article-title 108
Skeletal tissue engineering: opportunities and challenges
###end article-title 108
###begin article-title 109
Reparative Medicine: from tissue engineering to joint surface regeneration
###end article-title 109
###begin title 110
Figures and Tables
###end title 110
###begin p 111
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ex vivo </italic>
###xml 80 84 80 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 380 384 380 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 746 752 746 752 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c,d) </bold>
###xml 767 785 767 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">metalloproteinase </italic>
###xml 786 789 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP</italic>
###xml 791 793 791 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3 </italic>
###xml 797 804 797 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-13 </italic>
###xml 919 930 919 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; actin </italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 681 688 <span type="species:ncbi:9606">patient</span>
Ex vivo model of mechanical injury to adult human articular cartilage explants. (a) Adjacent explants from human adult articular cartilage were dissected and placed in culture in separate bacteriological Petri dishes. After 6 days, 1 explant was injured. At different time points the cultures were terminated for gene expression analysis, histochemistry and immunohistochemistry. (b) Safranin O staining of: a, freshly dissected normal articular cartilage; b, an adjacent explant after 7 days in culture; c, a further adjacent explant after 6 days in culture before injury plus 1 additional day after injury; and d, a typical freshly dissected explant from a preserved area from a patient who had undergone joint arthroplasty for osteoarthritis. (c,d) Time course of metalloproteinase (MMP)-3 and MMP-13 mRNA differential expression in injured versus uninjured explants. Values are normalized for the housekeeping gene beta actin and expressed as fold change of gene expression in the injured explants from paired uninjured controls. Diamonds indicate samples from preserved areas from joints affected by osteoarthritis; open squares indicate sample pairs from healthy cartilage. *p < 0.05; **p < 0.01. D, day(s); h, hours.
###end p 111
###begin p 112
###xml 27 54 27 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bone morphogenetic protein </italic>
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 105 109 105 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 154 158 154 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 344 355 344 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; actin </italic>
Differential expression of bone morphogenetic protein (BMP)-2 and FRZB mRNA following mechanical injury. (a) BMP-2 mRNA was significantly upregulated and (b) FRZB mRNA significantly down-regulated in most injured samples compared to uninjured adjacent controls. Values were calculated using a standard curve and normalized for the housekeeping beta actin gene. Diamonds indicate samples from preserved areas from joints affected by osteoarthritis; open squares indicate the sample pair from healthy cartilage.
###end p 112
###begin p 113
###xml 70 76 70 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a,b) </bold>
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2 </italic>
###xml 173 177 173 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 193 197 193 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 303 314 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; actin </italic>
###xml 572 578 569 575 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c-g) </bold>
###xml 626 630 623 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 666 670 663 667 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g) </bold>
###xml 722 726 719 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f) </bold>
###xml 785 789 782 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 1010 1014 1007 1011 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 1491 1495 1488 1492 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h) </bold>
###xml 1589 1594 1586 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2</italic>
###xml 1596 1600 1593 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB</italic>
###xml 1602 1620 1599 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">metalloproteinase </italic>
###xml 1621 1624 1618 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP</italic>
###xml 1625 1628 1622 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-3 </italic>
###xml 1632 1639 1629 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-13 </italic>
###xml 1840 1851 1837 1845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; actin </italic>
###xml 1893 1898 1887 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMP-2</italic>
###xml 1900 1906 1894 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-3 </italic>
###xml 1910 1917 1904 1911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-13 </italic>
###xml 1974 1978 1968 1972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB</italic>
###xml 1981 1983 1975 1977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1993 1995 1987 1989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 218 224 <span type="species:ncbi:9913">bovine</span>
###xml 1682 1687 <span type="species:ncbi:9606">human</span>
Activation of the bone morphogenetic protein (BMP) signaling pathway. (a,b) Time course of the differential expression of BMP-2 mRNA in injured versus uninjured explants in (a) the presence or (b) the absence of fetal bovine serum (FBS) in the culture medium. Values are normalized for the housekeeping beta actin gene and expressed as fold change of gene expression in the injured explants from paired uninjured controls. Diamonds indicate samples from preserved areas from joints affected by osteoarthritis; open squares indicate the sample pair from healthy cartilage. (c-g) Immunostaining for phosphorylated SMAD-1/-5 in: (c) freshly dissected normal cartilage; (g) the adjacent injured explant at day 1 after injury; (f) and the adjacent uninjured control at the same time-point. (d) Larger magnification of the area shown in the square in (c). In the freshly dissected sample, phosphorylated SMAD-1/-5-positive cells were detected predominantly in the intermediate layer indicated by the bracket in (c). (e) Image obtained by false coloring in red the image in (d) and superimposing it on the fluorescent image in the blue channel documenting the nuclear DAPI counterstain. The DAB precipitate in the phosphorylated SMAD-1/-5-positive cells quenched the DAPI fluorescence and, therefore, in this panel, phosphorylated SMAD-1/-5-positive cells appear red and the nuclei of negative cells appear blue. The top insets in (f,g) are large magnifications of the corresponding squared areas. (h) A graphic summary of the proportion of phospho-SMAD-1/-5-positive cells and the expression of BMP-2, FRZB, metalloproteinase (MMP)-3 and MMP-13 mRNAs in this experiment with normal adult human articular cartilage. Values are expressed as: percent of positive cells for phospho-SMAD-1/-5; relative gene expression normalized for the housekeeping beta actin gene; percent of the day 6 time point for BMP-2, MMP-3 and MMP-13 mRNA; and percent of the freshly dissected cartilage for FRZB. *p < 0.05; **p < 0.01. D, day(s); H, hours; SF, serum free medium.
###end p 113
###begin p 114
###xml 79 87 79 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
A figure showing modulation of the BMP and WNT pathway after mechanical injury in vivo in mice. Modulation of BMP and WNT pathway after mechanical injury in vivo in mice. 7 week old C57BL/6 male mice were challenged in a model of joint surface injury in vivo. In this model the knee joint surface is exposed by medial para-patellar arthrotomy and lateral patellar dislocation. A full thickness injury is made in the patellar groove using a custom made device in which the length of a 26G needle is limited by a glass bead (injured knee), or left uninjured (sham operated control). In either case the patellar dislocation is then reduced and the joint capsule and the skin sutured in separate layers and the mice allowed to walk freely. The animals were killed at different time-points for histological and histochemical analysis. A-B immunohistochemistry for FRZB in sham operated (A) and injured (B) articular cartilage 1 day after the operation. C-D immunohistochemistry for phosphorylated SMAD-1 in sham operated (A) and injured (B) articular cartilage 6 days after the operation. The asterisk indicates the site of injury (occupied by debris). The dashed line indicates the margin of the injury site.
###end p 114
###begin p 115
###xml 76 82 76 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a,b) </bold>
###xml 128 133 128 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 178 182 178 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 198 202 198 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 344 355 344 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#946; actin </italic>
###xml 610 616 607 613 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c-f) </bold>
###xml 649 654 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FRZB </italic>
###xml 671 675 668 672 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 689 693 686 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 784 790 781 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e,f) </bold>
###xml 861 865 858 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g) </bold>
###xml 1020 1024 1017 1021 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h) </bold>
###xml 1047 1051 1044 1048 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 1161 1167 1158 1164 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(j-m) </bold>
###xml 1253 1259 1247 1253 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(j-l) </bold>
###xml 1391 1395 1382 1386 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(k) </bold>
###xml 1417 1421 1405 1409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(l) </bold>
###xml 1467 1471 1455 1459 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(j) </bold>
###xml 1618 1622 1603 1607 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(m) </bold>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 223 229 <span type="species:ncbi:9913">bovine</span>
Components of the canonical WNT pathway in adult human articular cartilage. (a,b) Time course of the differential expression of FRZB mRNA in injured versus uninjured explants in (a) the presence or (b) the absence of fetal bovine serum (FBS) in the culture medium. Values were calculated using a standard curve, normalized for the housekeeping beta actin gene and expressed as fold change of gene expression in the injured explants from paired uninjured controls. Diamonds indicate samples from preserved areas from joints affected by osteoarthritis; open squares indicate sample pairs from healthy cartilage. (c-f) Immunohistochemical staining for FRZB protein (red) in (c) uninjured and (d) injured explants at the day 1 time point. Haematoxylin was used as a nuclear counterstain. (e,f) Larger magnifications of the boxed areas in (c) and (d), respectively. (g) Percentage of FRZB-positive cells in injured explants and in the paired uninjured controls from 3 independent donors as evaluated by immunohistochemistry. (h) Haematoxylin-eosin and (i) safranin O stainings of an explant with a relatively high degree of osteoarthritis (modified Mankin score 5). (j-m) Immunostaining for beta catenin in parallel, non-consecutive sections of (h) and (i). (j-l) Indirect immunofluorescence stainings for beta catenin from a parallel section in the area of (h) boxed with the dashed line (top). (k) beta catenin (green). (l) DAPI counterstain of the same section (blue). (j) The superimposition of (k) and (l). In this tissue, which is commonly called pannus, there were cells with a nuclear localization of beta catenin. (m) Immunohistochemistry showing the cytoplasmic localization of beta catenin in chondrocytes of the basal layer (area in (h) boxed with a solid line). *p < 0.05; **p < 0.01. D, day(s); H, hours; SF, serum free Medium.
###end p 115
###begin p 116
###xml 82 86 79 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 86 93 83 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Axin-2 </italic>
###xml 97 101 94 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 101 107 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
###xml 259 265 253 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c-f) </bold>
###xml 506 513 500 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">axin-2 </italic>
###xml 521 527 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-JUN </italic>
Activation of the WNT/beta catenin canonical pathway following mechanical injury. (a) Axin-2 and (b) c-JUN mRNAs, two known transcriptional targets of the WNT/beta catenin canonical pathway, were upregulated 1 day after injury compared to uninjured controls. (c-f) Paired cartilage explants were cultured in the presence of either 10 mM LiCl or 10 mM NaCl for 1 day and then terminated for gene expression analysis by quantitative real time PCR. Culture in the presence of LiCl induced the upregulation of axin-2 (c) and c-JUN (d) mRNAs, thereby confirming that these two genes are targets of the WNT/beta catenin canonical pathway in this experimental system. LiCl treatment also upregulated aggrecan and COL2A1 mRNA (e,f). **p < 0.01. D, day(s); h, hours.
###end p 116

